The five largest node targets identified were protein kinase 1 (AKT1), STAT3, JUN, interleukin-6 (IL-6), and mitogen-activated protein kinase 3 (MAPK3), which may be important targets for the treatment of lung adenocarcinoma with QSFZYL. This evidence concerns the gene MAPK3 and lung adenocarcinoma.